MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FLETCHER, J. E.
Right arrow Articles by SPECTOR, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FLETCHER, J. E.
Right arrow Articles by SPECTOR, A. A.

Molecular Pharmacology, Vol 13, 387-399, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Alternative Models for the Analysis of Drug-Protein Binding

JOHN E. FLETCHER 1 and ARTHUR A. SPECTOR 2

1 Laboratory of Applied Studies, Division of Computer Research and Technology, National Institutes of Health, Bethesda, Maryland 20014
2 Departments of Biochemistry and Medicine, University of Iowa, Iowa City, Iowa 52242

Mathematical models that are used to describe experimentally obtained drug-protein binding data often exhibit serious limitations. These limitations are demonstrated by a thorough examination of the binding of salicylate to human serum albumin. It is shown that simple models with nonintegral coefficients are inadequate for the interpretation of such binding data. A generalized mathematical formulation that includes both the Scatchard and stepwise equilibrium binding models is derived. This formulation is simpler to fit to data than the stepwise formulation, yet is not restricted to the Scatchard assumption of independent and noninteracting binding sites. This alternative formula is appropriate for the analysis of all equilibrium binding data. Even with this generalized mathematical formulation and sophisticated computerized fitting techniques, it is not possible to define precisely a single binding model for the salicylate binding data. The utility of model fitting in such a case is discussed, and procedures are demonstrated that characterize the information that can be obtained.

Note:
ACKNOWLEDGMENTS The authors gratefully acknowledge the generous cooperation of Dr. Roland F. Mais of the Veterans Administration Hospital, Neuropharmacology Research Service, Hines, Illinois, in supplying the data used to illustrate the methodology in this paper. We also acknowledge the technical assistance of Mrs. Elizabeth Fleetwood in the preparation of the manuscript.

Submitted on July 23, 1976
Accepted on December 14, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics